Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.

Article  PubMed  PubMed Central  Google Scholar 

Kelley RK, Bridgewater J, Gores GJ, et al. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353–63.

Article  CAS  PubMed  Google Scholar 

Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95–111.

Article  CAS  Google Scholar 

Bagante F, Spolverato G, Weiss M, et al. Defining long-term survivors following resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2017;21:1888–97.

Article  PubMed  Google Scholar 

Bridgewater J, Fletcher P, Palmer DH, et al. Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol. 2022;40:2048–57.

Article  PubMed  Google Scholar 

Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853–65.

Article  PubMed  Google Scholar 

Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364–77.

Article  PubMed  Google Scholar 

Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022. https://doi.org/10.1056/EVIDoa2200015.

Article  PubMed  Google Scholar 

Doussot A, Gonen M, Wiggers JK, et al. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg. 2016;223:493-505 e2.

Article  PubMed  PubMed Central  Google Scholar 

Hu LS, Zhang XF, Weiss M, et al. Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2019;26:2549–57.

Article  PubMed  Google Scholar 

NCCN Guidelines Version 3.2024 Intrahepatic Cholangiocarcinoma. 2024. https://www.nccn.org/professionals/physician_gls/pdf/btc.pdf. Accessed 1 Aug 2024.

European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79:181–208.

Fiz F, Rossi N, Langella S, et al. Radiomic analysis of intrahepatic cholangiocarcinoma: non-invasive prediction of pathology data: a multicenter study to develop a clinical-radiomic model. Cancers Basel. 2023;15:4204.

Article  PubMed  PubMed Central  Google Scholar 

Finch RJ, Malik HZ, Hamady ZZ, et al. Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg. 2007;94:1242–8.

Article  CAS  PubMed  Google Scholar 

Zhang XF, Bagante F, Chakedis J, et al. Perioperative and long-term outcome for intrahepatic cholangiocarcinoma: impact of major versus minor hepatectomy. J Gastrointest Surg. 2017;21:1841–50.

Article  PubMed  Google Scholar 

Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2019;26:1841–50.

Article  PubMed  Google Scholar 

Wu JY, Huang WT, He WB, et al. Long-term outcomes of anatomic vs non-anatomic resection in intrahepatic cholangiocarcinoma with hepatolithiasis: a multicenter retrospective study. Front Med Lausanne. 2023;10:1130692.

Article  PubMed  PubMed Central  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.

Article  PubMed  PubMed Central  Google Scholar 

GA Wells BS, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000.

Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805.

Article  PubMed  Google Scholar 

Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range, and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

Article  PubMed  Google Scholar 

Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan–Meier survival curves. BMC Med Res Methodol. 2012;12:9.

Article  PubMed  PubMed Central  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, et al. Response to: practical methods for incorporating summary time-to-event data into meta. Trials. 2013;14:391.

Article  PubMed  Google Scholar 

Wei Y, Royston P. Reconstructing time-to-event data from published Kaplan–Meier curves. Stata J. 2017;17:786–802.

Article  PubMed  PubMed Central  Google Scholar 

de Jong VMT, Moons KGM, Riley RD, et al. Individual participant data meta-analysis of intervention studies with time-to-event outcomes: a review of the methodology and an applied example. Res Synth Methods. 2020;11:148–68.

Article  PubMed  PubMed Central  Google Scholar 

Lueza B, Rotolo F, Bonastre J, et al. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis. BMC Med Res Methodol. 2016;16:37.

Article  PubMed  PubMed Central  Google Scholar 

Ke Q, Wang L, Lin Z, et al. Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score-matching and stabilized inverse probability of treatment-weighting analysis. BMC Cancer. 2023;23:850.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li B, Song JL, Aierken Y, et al. Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: a propensity score analysis. Sci Rep. 2018;8:17799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Ciren P, Danzeng A, et al. Anatomical resection improved the outcome of intrahepatic cholangiocarcinoma: a propensity score-matching analysis of a retrospective cohort. J Oncol. 2022;2022:4446243.

Article  PubMed  PubMed Central  Google Scholar 

Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254:824–9.

Article  PubMed  Google Scholar 

Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Surg Res. 2016;203:163–73.

Article  PubMed  Google Scholar 

Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg. 2020;155:823–31.

Article  PubMed  Google Scholar 

Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127–40.

Article  CAS  PubMed  Google Scholar 

Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246:295–300.

Article